Some natural and synthetic coumarins are cholinesterase inhibitors, which are a promising approach for the treatment of Alzheimer ́s disease and possible therapeutic applications in the treatment of Parkinsons ́s disease (Anand et al., 2012). This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.